BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10024836)

  • 1. [Special manufactured shoes for prevention of recurrent ulcer in diabetic foot syndrome].
    Striesow F
    Med Klin (Munich); 1998 Dec; 93(12):695-700. PubMed ID: 10024836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a new brand of stock 'diabetic' shoes to protect against diabetic foot ulcer relapse. A prospective cohort study.
    Busch K; Chantelau E
    Diabet Med; 2003 Aug; 20(8):665-9. PubMed ID: 12873296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and pilot testing of the DVA/Seattle Footwear System for diabetic patients with foot insensitivity.
    Reiber GE; Smith DG; Boone DA; del Aguila M; Borchers RE; Mathews D; Joseph AW; Burgess EM
    J Rehabil Res Dev; 1997 Jan; 34(1):1-8. PubMed ID: 9021621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial.
    Reiber GE; Smith DG; Wallace C; Sullivan K; Hayes S; Vath C; Maciejewski ML; Yu O; Heagerty PJ; LeMaster J
    JAMA; 2002 May; 287(19):2552-8. PubMed ID: 12020336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audit of cushioned diabetic footwear: relation to patient compliance.
    Chantelau E; Haage P
    Diabet Med; 1994; 11(1):114-6. PubMed ID: 8181241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality control and quality assurance in therapeutic shoes for the diabetic foot].
    Chantelau E; Jung V
    Rehabilitation (Stuttg); 1994 Feb; 33(1):35-8. PubMed ID: 8165361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufactured shoes in the prevention of diabetic foot ulcers.
    Uccioli L; Faglia E; Monticone G; Favales F; Durola L; Aldeghi A; Quarantiello A; Calia P; Menzinger G
    Diabetes Care; 1995 Oct; 18(10):1376-8. PubMed ID: 8721941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients.
    Waaijman R; de Haart M; Arts ML; Wever D; Verlouw AJ; Nollet F; Bus SA
    Diabetes Care; 2014 Jun; 37(6):1697-705. PubMed ID: 24705610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing plantar pressure in the neuropathic foot. A comparison of footwear.
    Lavery LA; Vela SA; Fleischli JG; Armstrong DG; Lavery DC
    Diabetes Care; 1997 Nov; 20(11):1706-10. PubMed ID: 9353613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic patient's compliance with bespoke footwear after healing of neuropathic foot ulcers.
    Breuer U
    Diabete Metab; 1994; 20(4):415-9. PubMed ID: 7843473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art design protocol for custom made footwear for people with diabetes and peripheral neuropathy.
    Bus SA; Zwaferink JB; Dahmen R; Busch-Westbroek T
    Diabetes Metab Res Rev; 2020 Mar; 36 Suppl 1(Suppl 1):e3237. PubMed ID: 31845547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-reducing insoles to prevent foot ulceration in high-risk diabetic patients.
    Lavery LA; LaFontaine J; Higgins KR; Lanctot DR; Constantinides G
    Adv Skin Wound Care; 2012 Nov; 25(11):519-24; quiz 525-6. PubMed ID: 23080240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Foot Australia guideline on footwear for people with diabetes.
    van Netten JJ; Lazzarini PA; Armstrong DG; Bus SA; Fitridge R; Harding K; Kinnear E; Malone M; Menz HB; Perrin BM; Postema K; Prentice J; Schott KH; Wraight PR
    J Foot Ankle Res; 2018; 11():2. PubMed ID: 29371890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for a randomized controlled trial to test for preventive effects of diabetic foot ulceration by telemedicine that includes sensor-equipped insoles combined with photo documentation.
    Ming A; Walter I; Alhajjar A; Leuckert M; Mertens PR
    Trials; 2019 Aug; 20(1):521. PubMed ID: 31439007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orthopaedic footwear against foot ulcers in diabetes].
    Bus SA
    Ned Tijdschr Geneeskd; 2014; 158():A7497. PubMed ID: 25322352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventing high-risk diabetic foot ulceration by a new method of custom-made shoes in high-risk patients. Prospective study].
    Tazi O; Debure C
    J Mal Vasc; 2008 Dec; 33(4-5):191-5. PubMed ID: 19036540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with wearing inadequate outdoor footwear in populations at risk of foot ulceration: A cross-sectional study.
    Barwick AL; Hurn SE; van Netten JJ; Reed LF; Lazzarini PA
    PLoS One; 2019; 14(2):e0211140. PubMed ID: 30789920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal investigation into the functional and physical durability of insoles used for the preventive management of neuropathic diabetic feet.
    Paton JS; Stenhouse E; Bruce G; Jones R
    J Am Podiatr Med Assoc; 2014; 104(1):50-7. PubMed ID: 24504577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal in-shoe foot pressure relief achieved by specially designed footwear in high risk diabetic patients.
    Donaghue VM; Sarnow MR; Giurini JM; Chrzan JS; Habershaw GM; Veves A
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):109-14. PubMed ID: 8792109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in attitudes and attributes of people using therapeutic shoes for diabetic foot complications.
    Jarl G; Alnemo J; Tranberg R; Lundqvist LO
    J Foot Ankle Res; 2019; 12():21. PubMed ID: 30976327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.